PROGASTRIN-RELEASING PEPTIDE (PROGRP) IN THE DIFFERENTIAL DIAGNOSTICS OF LUNG CARCINOMA

被引：0
|
作者：
Dastych, M. [1 ]
Tomiskova, M. [2 ,3 ]
Klabenesova, I. [1 ]
Skrickova, J. [2 ,3 ]
机构：
[1] Fac Hosp Brno, Dept Clin Biochem, Brno, Czech Republic
[2] Masaryk Univ, Fac Med, Dept Lab Methods, Brno, Czech Republic
[3] Masaryk Univ, Fac Med, Dept Pulm Dis & Tberculosis, Brno, Czech Republic
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2011年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：S232 / S232
页数：1
相关论文
共 50 条
  • [41] Aptamer based surface plasma resonance assay for direct detection of neuron specific enolase and progastrin-releasing peptide (31-98)
    Sun, Linlin
    Shen, Kemin
    Zhang, Jianbin
    Wan, Wenjuan
    Cao, Wenjun
    Wang, Zhijun
    Guo, Chongzheng
    RSC ADVANCES, 2021, 11 (51) : 32135 - 32142
  • [42] Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors
    Tutar, Nun
    Yetkin, Nur Aleyna
    Yazici, Cevat
    Onal, Omer
    Konta, Olgun
    Kelestemur, Fahrettin
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2019, 49 (03) : 774 - 781
  • [43] Circulating pro-gastrin releasing peptide (ProGRP) in patients with medullary thyroid carcinoma
    Giovanella, Luca
    Fontana, Martina
    Keller, Franco
    Campenni', Alfredo
    Ceriani, Luca
    Paone, Gaetano
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (09) : 1569 - 1573
  • [44] Progrp in differential diagnostics of SCLC and NSCLC patients
    Wojcik, E.
    Kulpa, J.
    Sas-Korczynska, B.
    Stasik, Z.
    TUMOR BIOLOGY, 2007, 28 : 98 - 98
  • [45] EXPRESSION OF AMIDATED AND NON-AMIDATED PEPTIDES DERIVED FROM PROGASTRIN-RELEASING PEPTIDE IN RENAL CANCERS, AND RENAL CANCER CELL LINES
    Ischia, Joseph
    Bolton, Damien M.
    Ischia, Liesl
    Patel, Oneel
    Lockie, Rachele
    Baldwin, Graham
    Schulkes, Arthur S.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 112 - 112
  • [46] The prognostic significance of serum chromogranin A (CGA), progastrin releasing peptide (ProGRP) and neuron-specific enolase (NSE) in patients with advanced NSCLC
    Benjamin, Nisman
    Heshing, N.
    Biran, H.
    Barak, V
    Peretz, T.
    TUMOR BIOLOGY, 2006, 27 : 78 - 78
  • [47] Pro-gastrin-releasing peptide (ProGRP) - A useful marker in small cell lung carcinomas
    Stieber, P
    Dienemann, H
    Schalhorn, A
    Schmitt, UM
    Reinmiedl, J
    Hofmann, K
    Yamaguchi, K
    ANTICANCER RESEARCH, 1999, 19 (4A) : 2673 - 2678
  • [48] Elevated serum progastrin-releasing peptide (31-98) level is a predictor of short response duration after hormonal therapy in metastatic prostate cancer
    Yashi, M
    Nukui, A
    Kurokawa, S
    Ochi, M
    Ishikawa, S
    Goto, K
    Kobayashi, Y
    Muraishi, O
    Tokue, A
    PROSTATE, 2003, 56 (04): : 305 - 312
  • [49] Preliminary radioimmunoimaging and biodistribution of 131iodine-labeled single-chain antibody fragment against progastrin-releasing peptide(31-98) in small cell lung cancer xenografts
    Hong Zhihui
    Shi Yizhen
    Liu Zengli
    Zhou Xiaolin
    Yang Yi
    Tang Jun
    CHINESE MEDICAL JOURNAL, 2014, 127 (11) : 2007 - 2011
  • [50] Pro-gastrin-releasing peptide (PROGRP) as a tumor biomarker in the evaluation of patients with medullary thyroid carcinoma
    Batista, M.
    Cunha, N.
    Carreiro, S.
    Macedo, H.
    Marques, B.
    Martins, R.
    Couto, J.
    Santos, J.
    Martins, T.
    Rodrigues, F.
    Valido, F.
    CLINICA CHIMICA ACTA, 2019, 493 : S130 - S131
12345